Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors
Clinical trial NCT02966548 · COMPLETED
Trial details
- NCT number
- NCT02966548
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-04
- Primary completion
- 2024-07-09
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.